Movement Disorders
Neuroleptic malignant syndrome
Jun. 19, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
(Left) Two symmetrically placed, intramedullary metastatic tumors have destroyed the first sacral segment of the spinal cord. (Hematoxylin-eosin; x7.8) (Center) Rostral to the tumors, the entire fifth lumbar segment has undergone coagulation necrosis, and the central portion has begun to liquefy. (Luxol fast blue; x8) (Right) Still more rostral, in the sixth thoracic segment, only the ventral portion of the dorsal columns is necrotic. (Hematoxylin-eosin; x7.2) (Contributed by Dr. Marc D Winkelman.)